| | | | | |
CTKB Cytek Biosciences, Inc. Common Stock | $4,5050 | +1,46% | $621,31M | $348,41K | |
FDMT 4D Molecular Therapeutics, Inc. Common Stock | $15,7700 | +2,47% | $620,51M | $566,63K | |
EIKN Eikon Therapeutics, Inc. Common Stock | $12,7050 | +13,84% | $619,88M | $409,93K | |
| $18,8180 | -1,48% | $619,48M | $100,20K | |
| $58,7050 | -1,07% | $618,62M | $22,03K | |
EMD Western Asset Emerging Markets Debt Fund, Inc | $10,5350 | +0,33% | $618,50M | $119,70K | |
CBNK Capital Bancorp, Inc. | $36,3000 | -0,71% | $617,08M | $21,19K | |
NRDS NerdWallet, Inc. Class A Common Stock | $10,0850 | -0,54% | $616,85M | $378,18K | |
| $68,3030 | -8,14% | $616,57M | $539,39K | |
TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | $45,5450 | +5,23% | $615,50M | $240,48K | |
CGNT Cognyte Software Ltd. Ordinary Shares | $8,3950 | -1,70% | $613,97M | $199,71K | |
BWB Bridgewater Bancshares, Inc. Common Stock | $21,1490 | -2,45% | $613,72M | $40,61K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | $9,5540 | -1,10% | $613,18M | $27,99K | |
ELMT The Elmet Group Co. Common Stock | $17,8220 | +0,92% | $612,93M | $153,78K | |
| $7,2950 | +3,04% | $611,79M | $488,12K | |
